Monreal E, Gómez-Ballesteros R, Meca-Lallana V, Caminero AB, Meca-Lallana JE, Martínez-Yélamos S, Landete L, García-Domínguez JM, Agüera E, García-Arcelay E, Medrano N, Villar LM, Maurino J

Neuropsychiatric Disease and Treatment 2025, 21:1523-1531

Published Date: 29 July 2025

Original Research

Machine Learning and Interpretability Study for Predicting 30-Day Unplanned Readmission Risk of Schizophrenia: A Retrospective Study

Tan Y, Chen G, Wang S, Zhan X, Cheng R, Qiao L, Zhang Z, Liu Y

Neuropsychiatric Disease and Treatment 2025, 21:1509-1521

Published Date: 28 July 2025

Corrigendum

An Effectiveness Trial of an Exercise Physiologist Service to Improve Quality of Life in Adults with Severe Mental Illness: Protocol for the MOVEMENT Study [Corrigendum]

Chapman JJ, Siskind D, Yung AR, Lee YY, Arnautovska U, Scott JG, Burke K, Malacova E, Korman N, Wyder M, Doohan MA, Keating SE, Parker S, Walker ME, Hu D, O'Brien J, Lau G, Pratt GF, Rosenbaum S, Curtis J, Chatterton ML, Simmons L, Wheeler AJ

Neuropsychiatric Disease and Treatment 2025, 21:1507-1508

Published Date: 25 July 2025

Original Research

Influence of Polymorphisms in Gene SATB2 on Antipsychotics Response in Chinese Han Population

Du X, Wang Y, Zhang Q, Gao Y, Wang X, Zhao W, Hu X, Zhang Y, Xu Y, Chen B, Zhang J, Liu S, Li X

Neuropsychiatric Disease and Treatment 2025, 21:1495-1505

Published Date: 25 July 2025

Original Research

Construction and Brain Validation of circRNAs-miRNAs-mRNAs Regulatory Axis in Early-Onset Schizophrenia

Zhang X, Li Z, Li R, Wang X, Liu H, Du X, Gao Y, Liu S, Xu Y

Neuropsychiatric Disease and Treatment 2025, 21:1481-1493

Published Date: 22 July 2025

Original Research

Role of LncRNA in Trauma Susceptibility and Resilience to Post-Traumatic Stress Disorder (PTSD): A Pilot Study in the African American Population

Sadhukhan T, Rai N, Misiak-Christian M, Hipolito MMS, Sadhukhan S, Shelby M, Mejía Mondragón CI, Idowu A, Gondringer A, Kalejaiye A, Li J, Islam MN, Ressom HW, Nwulia EA

Neuropsychiatric Disease and Treatment 2025, 21:1469-1479

Published Date: 21 July 2025

Review

Efficacy Evaluation of Virtual Reality in Cognitive and Psychological Rehabilitation After Brain Injury: A Systematic Review and Meta-Analysis

Zhang M, Wang E, Shan H, Zhu S

Neuropsychiatric Disease and Treatment 2025, 21:1455-1468

Published Date: 21 July 2025

Short Report

Caregiver-Reported ADHD in Shanghai, China: Prevalence, Associated Factors, and Implications for Diagnosis

Wang S, Zhang M, Huang L, Zhang X, Xue Z

Neuropsychiatric Disease and Treatment 2025, 21:1447-1453

Published Date: 19 July 2025

Original Research

Predictors of Changes in Depressive Symptoms with Major Depressive Disorder - A Naturalistic 6-month Follow-up Study

Inano R, Sugawara N, Kawamata Y, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2025, 21:1435-1446

Published Date: 19 July 2025

Original Research

The Association of Glycemic Gap with Cognitive Function After Ischemic Stroke or Transient Ischemic Attack

Min Y, Xu Q, Wang Y, Li Z

Neuropsychiatric Disease and Treatment 2025, 21:1425-1433

Published Date: 19 July 2025

Clinical Trial Report

Esketamine Optimized the Efficacy of Dexmedetomidine in Treating Sleep Disorders with Comorbid Depression

Ding Y, Wang Z, Huang J, Yi Y, Wu Z

Neuropsychiatric Disease and Treatment 2025, 21:1409-1423

Published Date: 12 July 2025

Study Protocol

An Effectiveness Trial of an Exercise Physiologist Service to Improve Quality of Life in Adults with Severe Mental Illness: Protocol for the MOVEMENT Study

Chapman JJ, Siskind D, Yung AR, Lee YY, Arnautovska U, Scott JG, Burke K, Malacova E, Korman N, Wyder M, Doohan MA, Keating SE, Parker S, Walker ME, Hu D, O’Brien J, Lau G, Pratt GF, Rosenbaum S, Curtis J, Chatterton ML, Simmons L, Wheeler AJ

Neuropsychiatric Disease and Treatment 2025, 21:1399-1408

Published Date: 11 July 2025

Clinical Trial Report

Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-Release Tablets on Somatic Symptoms of Major Depressive Disorder: A Prospective, Single-Arm, Multicenter Clinical Study

Wang Y, He M, Zhang H, Luo Y, Sun X, Yao Z, Tang H, Yan R, Du X, Li Z, Peng D, Wang Z

Neuropsychiatric Disease and Treatment 2025, 21:1387-1397

Published Date: 9 July 2025

Original Research

Prevalence, Diagnosis, and Treatment of Generalized Anxiety Disorder in Working Individuals: A Cross-Sectional Study Using Health Claims and Survey Data in Japan

Matsuyama S, Otsubo T, Nomoto K, Misago R, Higa S

Neuropsychiatric Disease and Treatment 2025, 21:1371-1385

Published Date: 9 July 2025

Original Research

Nomogram Model for Predicting Risk of Postoperative Delirium in Adult Liver Transplant Patients: A Retrospective Study

Yu LL, Gong Y, Fang F, Wang T, Cang J

Neuropsychiatric Disease and Treatment 2025, 21:1359-1369

Published Date: 8 July 2025

Clinical Trial Report

Clinical Efficacy of Mind-Regulating Acupuncture on Post-Stroke Depression Based on the “Microbiota-Gut-Brain Axis” Theory: A Randomized Controlled Study

Xie J, Li J, Sun Q, Jiang J

Neuropsychiatric Disease and Treatment 2025, 21:1349-1358

Published Date: 7 July 2025

Original Research

A Clinical-Metabolic Prediction Model for Suicidal Behaviors Risk Stratification in First-Admission Major Depressive Disorder: A Cross-Sectional Analysis

Geng L, Zhang S, Yan J, Wang R

Neuropsychiatric Disease and Treatment 2025, 21:1339-1348

Published Date: 5 July 2025

Original Research

Accuracy of Death Certificates in Attributing Mortality to Alzheimer’s Disease and Other Dementias in Japanese Psychiatric Hospitals

Sato K, Shioda K, Suda S

Neuropsychiatric Disease and Treatment 2025, 21:1325-1337

Published Date: 5 July 2025

Original Research

Evaluating the Therapeutic Efficacy of rTMS Combined with Low-Dose Antipsychotic Medication in Somatic Symptom Disorder

Wu J, Wang T, Jiang X

Neuropsychiatric Disease and Treatment 2025, 21:1315-1324

Published Date: 3 July 2025

Original Research

Blood Uric Acid in Mild Cognitive Impairment: A Cross-Sectional Study of Older Chinese Adults

Xue L, Xiao X, Mao X, Zhang X, Liu Y, Wu B

Neuropsychiatric Disease and Treatment 2025, 21:1307-1314

Published Date: 28 June 2025

Original Research

A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMART

Arnautovska U, Ritchie G, Soole R, Menon A, Korman N, Milton A, Varnfield M, Kelly JT, Jansen PM, Baker A, Ireland D, Russell AW, Chapman J, Mulligan K, Hirani SP, Vitangcol KJ, McKeon G, Siskind D

Neuropsychiatric Disease and Treatment 2025, 21:1289-1305

Published Date: 26 June 2025

Corrigendum

Earlier Use of Long-Acting Injectable Paliperidone Palmitate Once-Monthly versus Oral Antipsychotics in Patients with Schizophrenia: An Integrated Patient-Level Meta Analysis of the PROSIPAL and PRIDE Studies [Corrigendum]

Sajatovic M, Doring M, Lopena OJ, Johnston K, Turkoz I, Josiah N, Obando C

Neuropsychiatric Disease and Treatment 2025, 21:1287-1288

Published Date: 27 June 2025

Original Research

Auditory N1, N2, and MMN to Pure-Tone and Consonant–Vowel Stimuli in Developmental Dyslexia and Benign Rolandic Epilepsy: A Progressive Insight Into the Underlying Disruptive Neurophysiology

Tomé D, Pereira I, Vieira MC, Soares AP, Barbosa F

Neuropsychiatric Disease and Treatment 2025, 21:1271-1286

Published Date: 25 June 2025

Original Research

Severity and Prognosis of Vascular Dementia in Patients with Acute Cerebral Infarction Combined with H-Type Hypertension and Its Correlation with Uric Acid Levels

Hong Y, Feng M

Neuropsychiatric Disease and Treatment 2025, 21:1261-1270

Published Date: 24 June 2025

Study Protocol

Effects of Binaural Beat Music and Esketamine for ECT in the Treatment of Major Depressive Disorder: A Randomized Controlled Trial Protocol

Zhang Y, Ke Z, Luo J, Chen Q, Xu X, Jiang X, Xiong J

Neuropsychiatric Disease and Treatment 2025, 21:1249-1260

Published Date: 24 June 2025

Clinical Trial Report

An Evaluation a PrEP-Focused HIV Prevention Intervention Tailored for Individuals with Opioid Use Disorder and Cognitive Dysfunction

Mistler CB, Huedo-Medina TB, Shrestha R, Gunstad J, Zelenev A, Copenhaver MM

Neuropsychiatric Disease and Treatment 2025, 21:1235-1248

Published Date: 24 June 2025

Review

Traditional Chinese Medicine in the Management of Anxiety Disorders: A Narrative Review of Theoretical Foundations, Clinical Applications, and Modern Integrative Approaches

Wang Q, Wang D, Lv Y, Li Q

Neuropsychiatric Disease and Treatment 2025, 21:1215-1233

Published Date: 18 June 2025

Original Research

Long-Term Symptomatic and Functional Remission with Paliperidone Palmitate 6-Monthly Treatment in Schizophrenia: A 3-Year Post-Hoc Analysis

Hamilton JM, Johnston KL, Simples Jnr J, Turkoz I, Lim L, Antunes J, Obando C, Mattingly G

Neuropsychiatric Disease and Treatment 2025, 21:1203-1214

Published Date: 18 June 2025

Original Research

Effects of Parental Attitudes in Childhood on Depressive Symptoms Through Trait Anxiety and Negative Life Events in Adult Volunteers

Hayashida T, Kikkawa M, Masuya J, Ono M, Ito S, Nibuya R, Takashio O, Tamada Y, Hashimoto N, Inoue T

Neuropsychiatric Disease and Treatment 2025, 21:1191-1201

Published Date: 15 June 2025

Original Research

Human Neural Stem Cells Reduce Hypoxia-Ischemic Neurological Impairment Through the Regulation of Inflammatory M1/M2 Microglias in Rats

Ding YB, Zhao Y, Chen BY, Wang Q, Wang ZY, Luan Z, Yi B

Neuropsychiatric Disease and Treatment 2025, 21:1173-1190

Published Date: 9 June 2025

Clinical Trial Report

Dynamic Changes in ALFF and DC in Subthreshold Depression Before and After ICBT Intervention

Wang Y, Ying Y, Zhu Z, Wang L, Yang Y, Zhang L, Yu W, Liang Y, Zhang H, Ji Y, Pan Y

Neuropsychiatric Disease and Treatment 2025, 21:1161-1172

Published Date: 7 June 2025

Original Research

Association Between Daytime Sleepiness and Quality of Life in Chinese Adolescents: A Moderated Mediation of Cognitive Dysfunction and Depressive Symptoms

Li W, Hu N, Yang X, Zheng W, Tong J, Song J, Song Y, Gao X, Wang Z, Liu W, Wang L, Tan Y, Wang C, Deng H

Neuropsychiatric Disease and Treatment 2025, 21:1143-1159

Published Date: 3 June 2025

Original Research

Effects of Intelligence Levels and Autistic Severity on Adaptive Functioning and Cognitive-Adaptive Functioning Gaps in School-Aged Children with Autism Spectrum Disorder

Jin WY, Song C, Wang YY, Liu XL, Li WH, Wu LL, Zhu ZW

Neuropsychiatric Disease and Treatment 2025, 21:1131-1142

Published Date: 4 June 2025

Original Research

Auto-Immune Glial Fibrillary Acidic Protein Astrocytopathy with Active Intrathecal Epstein-Barr Virus: A Single-Center Case Series Report

Yu X, Zou Y, Li M, Wang L, Feng W, Wei L, Yang L, He J, Bu H, Li Y

Neuropsychiatric Disease and Treatment 2025, 21:1119-1130

Published Date: 31 May 2025

Original Research

Alterations in White Matter Structure in Sleep-Related Epilepsies: A TBSS-Based Diffusion Tensor Imaging Study

Wang Z, Liu W, Feng X, Wang Q, Ning X, Xing W

Neuropsychiatric Disease and Treatment 2025, 21:1109-1118

Published Date: 30 May 2025

Letter

Methodological Considerations in Humidex and Schizophrenia Research [Letter]

Zubaidah T, Sofia N

Neuropsychiatric Disease and Treatment 2025, 21:1107-1108

Published Date: 23 May 2025

Original Research

Network Analysis of Anxiety, Insomnia, Depression, and Suicide Attempts in Chinese Outpatients with Somatic Symptom Disorder

Fang J, Tang H, Liao H, Zhong Y, Li Y, Liao Y, Li Y

Neuropsychiatric Disease and Treatment 2025, 21:1091-1105

Published Date: 22 May 2025

Original Research

Machine Learning Based Early Diagnosis of ADHD with SHAP Value Interpretation: A Retrospective Observational Study

Zhang X, Xiao X, Luo Y, Xiao W, Cao Y, Chang Y, Wu D, Xu H, Zhao J, Deng X, Jiang Y, Xie R, Liu Y

Neuropsychiatric Disease and Treatment 2025, 21:1075-1090

Published Date: 21 May 2025

Original Research

Alterations of Blood Plasma Metabolites, Including Kynurenine and Tryptophan, in Bipolar Disorder

Nakayama T, Umehara H, Mawatari K, Tomioka Y, Yoshida T, Matsuda H, Matsumoto Y, Masuda R, Kamishikiryo T, Fuchikami M, Nakataki M, Takahashi A, Tajima A, Okada G, Numata S

Neuropsychiatric Disease and Treatment 2025, 21:1067-1073

Published Date: 18 May 2025

Review

The Roles of Heart Rate Variability in Cerebral Stroke

Wang H, Jiang J, Zhou G, Zhang Y

Neuropsychiatric Disease and Treatment 2025, 21:1057-1065

Published Date: 16 May 2025

Short Report

Aripiprazole Lauroxil Every 2 Months or Paliperidone Palmitate Monthly for Acute Schizophrenia: A Post Hoc Analysis of PANSS Five-Factor Scores in the ALPINE Trial

Citrome L, Dunbar M, McGrory JA

Neuropsychiatric Disease and Treatment 2025, 21:1047-1055

Published Date: 14 May 2025

Review

Efficacy and Tolerability of Viloxazine Compared to Placebo on Emotional, Behavioral, and Executive Functioning in Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis

Maneeton P, Maneeton B, Winichaikul Y, Kawilapat S, Kienngam N, Maneeton N

Neuropsychiatric Disease and Treatment 2025, 21:1029-1045

Published Date: 12 May 2025

Original Research

Association Between Health-Related Physical Fitness and Depressive Symptoms in Chinese Adolescents: A Nationwide Cross-Sectional Study Under the Healthy China Initiative

Cao YB

Neuropsychiatric Disease and Treatment 2025, 21:1019-1027

Published Date: 9 May 2025

Clinical Trial Report

The Correlation Between DRD2 and COMT Gene Polymorphisms, HPT and HPG Axes Functions, and Antipsychotic Drug-Induced Hyperprolactinemia and Macroprolactinemia

Wang Z, Li J, Chen H, Jin H, Wang S, Hu X

Neuropsychiatric Disease and Treatment 2025, 21:1011-1017

Published Date: 8 May 2025

Original Research

Potential Value of Plasma-Based Biomarkers for Prediction of Episodic Memory Performance and Identification of Individuals with Amnestic Mild Cognitive Impairment

Wang M, Zhang Z, Shi Y, Shu H, Xie C, Ren Q, Wang Z

Neuropsychiatric Disease and Treatment 2025, 21:999-1010

Published Date: 5 May 2025

Original Research

Association of Exposure to Humidex with Schizophrenia Admissions in Qingdao, China: A Time-Series Study

Han H, Liu J, Wang L, Li G, Wang T

Neuropsychiatric Disease and Treatment 2025, 21:989-997

Published Date: 29 April 2025

Original Research

Altered Gut Microbiota and Plasma Metabolome Profiles Characterize Depression Individuals with Ischemic Stroke: A Comparative Analysis

Cao N, Lv D, Liu Y, Zhang H, Zhang X

Neuropsychiatric Disease and Treatment 2025, 21:973-987

Published Date: 29 April 2025

Original Research

Potential Inflammatory Biomarkers and Differential Gut Microbiota in Cognitive Impairment After Ischemic Stroke

Wu L, Jiang Y, Xu W, Wang L, Li L, Zhang C, Huang K, Yang Y, Dai J, Zhou F

Neuropsychiatric Disease and Treatment 2025, 21:965-972

Published Date: 28 April 2025

Original Research

Beyond Anxiety and Depression: Multidimensional Psychiatric Screening for Neurological Patients Based on HADS and BSI-53

Kujovic M, Benz D, Baumann B, Engelke C, Margittai Z, Christl J, Seitz RJ, Menge T, Bahr C, Riesbeck M, Meisenzahl E, Schmidt-Kraepelin C

Neuropsychiatric Disease and Treatment 2025, 21:955-964

Published Date: 26 April 2025

Original Research

Associations of Vocal Features, Psychiatric Symptoms, and Cognitive Functions in Schizophrenia

Natsuyama T, Chibaatar E, Shibata Y, Okamoto N, Cruz Victorino JN, Ikenouchi A, Shibata T, Yoshimura R

Neuropsychiatric Disease and Treatment 2025, 21:943-954

Published Date: 23 April 2025

Original Research

Exploration of Epigenetic Mechanisms and Biomarkers Among Patients with Very-Late-Onset Schizophrenia-Like Psychosis

Gan Y, Yue W, Sun J, Yang D, Fang C, Zhou Z, Yin J, Zhou H

Neuropsychiatric Disease and Treatment 2025, 21:927-942

Published Date: 22 April 2025

Original Research

Clinical Efficacy of Acupuncture Combined with Escitalopram Oxalate in the Treatment of Mild-to-Moderate Post-Stroke Depression

Liu Y, Zhang G, Li J, Lv Y, Qi R

Neuropsychiatric Disease and Treatment 2025, 21:917-925

Published Date: 17 April 2025

Original Research

An Event-Related Potential Study on Facial Recognition in Children with and without Autism Spectrum Disorders

Deng JR, Tong M, Zhang XT, Lin ZP, Wang Z, Long J, Chen ZM

Neuropsychiatric Disease and Treatment 2025, 21:903-916

Published Date: 15 April 2025

Original Research

Association Between the Time of Exposure to Electronic Screen and Anxiety and Depression After Controlling Demographics, Exercises, and Lifestyles Among University Students

Zhang L, Zhao S, Zhao S, Ke Y, Yang W, Lei M

Neuropsychiatric Disease and Treatment 2025, 21:885-902

Published Date: 15 April 2025

Original Research

Prevalence and Associated Factors of Depression in Patients with Ischaemic Stroke: A Cross-Sectional Study

Li Y, Qin W, Chen Y, Zhang D, Zhao Y

Neuropsychiatric Disease and Treatment 2025, 21:875-883

Published Date: 14 April 2025

Short Report

The 4977 Bp Deletion of Mitochondrial DNA as a Potential Trait Marker for Major Depressive Disorder

He Y, Yang X, Li Z, Liu W, Tang J, Chen X

Neuropsychiatric Disease and Treatment 2025, 21:867-873

Published Date: 13 April 2025

Original Research

Biomarkers of Suicidal Ideation in Depression: Insights From VMHC Analysis and Machine Learning

Wang X, Liu F, Hu X, Zhang Q, Guan X, Wu J, Long X, Lu Z

Neuropsychiatric Disease and Treatment 2025, 21:855-865

Published Date: 13 April 2025

Original Research

Impact of Emotional Blunting on Patient Social Function and Depressive Symptoms: A Post Hoc Analysis of a Web-Based Survey in Japanese Patients with Major Depressive Disorder

Kikuchi T, Iga JI, Hattori A, Tokuda F, Moriguchi Y, Hoshino T

Neuropsychiatric Disease and Treatment 2025, 21:841-854

Published Date: 12 April 2025

Original Research

Correlation Between Systemic Immune Inflammatory Index and Suicidal Attempt in Patients with First-Episode Untreated Depression and its Risk Factors

Wu Y, Jiang W, Chen M, Jiang Q, Huang H, Guo W, Yuan Y

Neuropsychiatric Disease and Treatment 2025, 21:827-839

Published Date: 11 April 2025

Study Protocol

Ascorbic Acid and Esketamine for Mental Disorders in Women with Miscarriage: A Randomized Controlled Double-Blind Trial Protocol

Ke Z, Zhang Y, Cai B, Luo J, Ma Y, Chen Q, Deng L

Neuropsychiatric Disease and Treatment 2025, 21:815-825

Published Date: 11 April 2025

Original Research

Acupuncture Ameliorates Alzheimer’s-Like Cognitive Impairment and Pathological Changes via Regulating the Intestinal Fungal Community in APP/PS1 Mice

Hao X, Ding N, Zhang Y, Wu M, Tao Y, Li Z

Neuropsychiatric Disease and Treatment 2025, 21:799-813

Published Date: 9 April 2025

Original Research

Disruption of Multimodal Brain Networks and Structural-Functional Coupling in Adolescents with Major Depressive Disorder

Wang Y, Wei J, Yan Y, Wang M, Fan H, Du Y, Yang X, Ma X, Ma X

Neuropsychiatric Disease and Treatment 2025, 21:791-798

Published Date: 9 April 2025

Original Research

Dyadic Effects of Stigma and Self-Compassion on Resilience of Schizophrenic Patients and Caregivers During Recovery: An Actor-Partner Interdependence Mediation Model

Feng J, Du C, Xiao Y, Liu J, Chen Q, Liu Y, Zhang Z

Neuropsychiatric Disease and Treatment 2025, 21:775-790

Published Date: 8 April 2025

Original Research

Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed

Citrome L, Neugebauer NM, Meli AA, Kando J

Neuropsychiatric Disease and Treatment 2025, 21:761-773

Published Date: 5 April 2025

Original Research

Psychological Disturbances and Associated Risk Factors in Chinese Mine Rescuers: A Cross-Sectional Study

Hou Y, Meng Y, Wu F, Yang S, Yang F

Neuropsychiatric Disease and Treatment 2025, 21:751-760

Published Date: 5 April 2025

Original Research

Relationship Between Peritraumatic Dissociation, Beliefs About Losing Control, Resilience, and PTSD on Earthquake Survivors in Turkey

Unal GA, Kocatepe Avcı U, Ozdemir E

Neuropsychiatric Disease and Treatment 2025, 21:741-750

Published Date: 5 April 2025

Original Research

An Alternative Approach to Future Diagnosis: Can Generalized Anxiety Disorder Be Distinguished From Major Depressive Disorder, Healthy People by Differentially Expressed lncRNAs in Peripheral Blood

Kong L, Zhang L

Neuropsychiatric Disease and Treatment 2025, 21:729-739

Published Date: 4 April 2025

Original Research

Exogenous GABA Alleviates Tourette Syndrome-Like Behavior in Sprague-Dawley Rats by Altering Gut Microbiota and Striatum Metabolism

Xu Y, Li LN, He XJ, Wang S, Li X, Feng H, Zhang HF, Song L, Shi HS, Tian XY

Neuropsychiatric Disease and Treatment 2025, 21:711-727

Published Date: 4 April 2025

Original Research

Functional and Structural Network Alterations in HIV-Associated Asymptomatic Neurocognitive Disorders: Evidence for Functional Disruptions Preceding Structural Changes

Zhou Z, Gong W, Hu H, Wang F, Li H, Xu F, Li H, Wang W

Neuropsychiatric Disease and Treatment 2025, 21:689-709

Published Date: 1 April 2025

Original Research

Genotypic and Phenotypic Characteristics of Pediatric X-Adrenoleukodystrophy in a Chinese Cohort

Zhang Y, Shi X, Huang J, Wang C, Wu S, Tian G, Jia J, Chen Y

Neuropsychiatric Disease and Treatment 2025, 21:677-687

Published Date: 27 March 2025

Original Research

Direct and Indirect Effects of Risk Perception and Risk Information on PTSD in Frontline Healthcare Workers

Wu L, Geng S, Zhou Y, Jiao R, Ouyang H, Cheng S, Shang Z, Yan W, Wang J, Jia Y, Li X, Liu W

Neuropsychiatric Disease and Treatment 2025, 21:663-676

Published Date: 21 March 2025

Review

Anxiolytic, Antidepressant and Healthy Sleep-Promoting Potential of Rosmarinic Acid: Mechanisms and Molecular Targets

Priya V, Srinivasan D, Priyadarsini S, Dabaghzadeh F, Rana SS, Chengaiyan JG, Sudesh R, Ahmad F

Neuropsychiatric Disease and Treatment 2025, 21:641-661

Published Date: 20 March 2025

Original Research

Feasibility of Serum Peroxiredoxin 2 as a Biochemical Indicator for Reflecting Severity and Prognosticating Stroke-Associated Pneumonia, Early Neurological Deterioration and Poor Neurological Outcomes in Acute Supratentorial Intracerebral Hemorrhage: An Observational Analytical Clinical Study

Zhang C, Zhang G, Ye Z, Hu G, Ge S, Luo K, Li Z

Neuropsychiatric Disease and Treatment 2025, 21:621-640

Published Date: 20 March 2025

Clinical Trial Report

A Pilot Study of Remote Ischemic Conditioning in Preventing Post-Stroke Depression

Li W, Qin Y, Wang J, Li L, Gao J, Xu X, Wu Z, Ji X, Wang Y, Gao K, Ren M, Shao X

Neuropsychiatric Disease and Treatment 2025, 21:611-619

Published Date: 19 March 2025

Letter

Inconsistent Cognitive Assessment Criteria in PD-MCI Research [Letter]

Wang J

Neuropsychiatric Disease and Treatment 2025, 21:609-610

Published Date: 19 March 2025

Original Research

The Association Between Antidepressant Treatment and Heart Rate Deceleration Capacity in Patients With Mood disorders—A Potential New Predictor of Sudden Cardiac Death

Okayasu H, Sugawara N, Fujii K, Ozeki Y, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2025, 21:597-607

Published Date: 18 March 2025

Review

Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia

Citrome L, Correll CU, Cutler AJ, Dunbar M, Hoberg AR, Hopkinson C, Mattingly GW, McGrory JA, Rege B, Weiden PJ, McDonnell D

Neuropsychiatric Disease and Treatment 2025, 21:575-596

Published Date: 14 March 2025

Original Research

Exploring Gender Differences in the Relationship Between Thyroid Function and Aggressive and Impulsive Behaviors in Patients with Major Depressive Disorder

Zhao S, Wang A, Han Y, Song C, Zhang H, He K, Chen J

Neuropsychiatric Disease and Treatment 2025, 21:563-574

Published Date: 14 March 2025

Review

Transdiagnostic Effects of Schizophrenia Polygenic Scores on Treatment Outcomes in Major Psychiatric Disorders

Serretti A, Baune BT

Neuropsychiatric Disease and Treatment 2025, 21:547-562

Published Date: 13 March 2025

Research Letter

Environmental Factors in the Etiology of Mental Disorders in the Czech Republic: Final Results

Hosak L, Hurdova K, Hrnciarova J, Zapletalova J, Koncelikova D, Latalova K

Neuropsychiatric Disease and Treatment 2025, 21:541-545

Published Date: 12 March 2025

Corrigendum

Predictive Value of NT-proBNP for Functional Outcome of Ischemic Stroke Without Cardiac Disease: A Prospective, Observational Study [Corrigendum]

Liu R, Chen G, Zhao N, Yue W

Neuropsychiatric Disease and Treatment 2025, 21:539-540

Published Date: 10 March 2025

Review

A Review of Clinical Advances and Challenges in Clozapine-Induced Myocarditis

Li M, Bai Y, Wang Y, Xing H, Zhang Y, Ding W, Ye H, Ma L, Wang W, Bao T

Neuropsychiatric Disease and Treatment 2025, 21:525-538

Published Date: 7 March 2025

Original Research

The Correlation Between RIN3 Gene Methylation and Cognitive Impairment in Parkinson’s Disease

Yu X, Zhu K, Wang T, Li HY, Zhang X, Zhong X, Wang L

Neuropsychiatric Disease and Treatment 2025, 21:511-524

Published Date: 7 March 2025

Original Research

Duration Mismatch Negativity in Adults With Autism Spectrum Disorder Versus Healthy Controls

Sato A, Itagaki S, Ohnishi T, Osakabe Y, Hoshino H, Kanno K, Suzutani K, Wada T, Miura I, Yabe H

Neuropsychiatric Disease and Treatment 2025, 21:503-510

Published Date: 5 March 2025

Clinical Trial Report

Optimal Treatment of Magnetic Seizure Therapy (MST) in Patients with Clozapine-Resistant Schizophrenia (CRS)

Xiang Q, Xu P, Zhai Z, Jia Y, Li C, Liu D

Neuropsychiatric Disease and Treatment 2025, 21:491-501

Published Date: 5 March 2025

Original Research

Characteristics of Gut Microbiota and Plasma Metabolites in Patients with Post-Stroke Depression

Yan C, Si T, Zheng W, Huang L, Wen L, Shen H, Qu M

Neuropsychiatric Disease and Treatment 2025, 21:477-489

Published Date: 4 March 2025

Original Research

The Prevalence of Tardive Dyskinesia In Patients With Schizophrenia Treated With Antipsychotics In Malaysia

Nedunjelian A, Ng CG, Lim PK, Sulaiman AH, Koh OH, Francis B

Neuropsychiatric Disease and Treatment 2025, 21:465-475

Published Date: 5 March 2025

Editorial

Neuropsychiatric Disease and Treatment: 20 Years on

Pinder RM

Neuropsychiatric Disease and Treatment 2025, 21:463-464

Published Date: 1 March 2025

Original Research

Neuropsychiatric Approaches to Essential and Functional Tremor: A Comparative Study

Balal M, Çakmak S, Erdem M, Demirkiran M

Neuropsychiatric Disease and Treatment 2025, 21:451-462

Published Date: 2 March 2025

Original Research

Uncovering Potential Biomarkers and Constructing a Prediction Model Associated with Iron Metabolism in Parkinson’s Disease

Cheng Y, Zhai H, Liu Y, Yang Y, Fang B, Song M, Zhong P

Neuropsychiatric Disease and Treatment 2025, 21:437-449

Published Date: 28 February 2025

Review

Preclinical Evidence for the Use of Brexpiprazole + Antidepressant Treatment for Major Depressive Disorder and Post-Traumatic Stress Disorder: A Systematic Review

Brubaker M, Kapadia S, Maletic V, Chambers JS, Watling CP, Citrome L

Neuropsychiatric Disease and Treatment 2025, 21:421-436

Published Date: 28 February 2025

Original Research

Activation of the Reelin/GSK-3β/p-Tau Signaling Pathway in the Hippocampus of Patients with Temporal Lobe Epilepsy

Lin J, Lin X, Fu YJ, Li X, Li X, Wang Y, Zhao L, Yu S, Piao YS

Neuropsychiatric Disease and Treatment 2025, 21:409-419

Published Date: 27 February 2025

Original Research

Understanding Relapse in Bipolar Disorder at a Tertiary Mental Health Facility in Uganda

Kimbowa P, Nalwoga V, Namwanje S, Ssekulima JK, Anguparu SW

Neuropsychiatric Disease and Treatment 2025, 21:395-408

Published Date: 27 February 2025

Clinical Trial Report

Examination on the Acceptability, Feasibility and Effectiveness of a Digital Cognitive Training Software in Patients With Stable Schizophrenia in China

Yang L, Tang Y, Zhu J, Xu L, Wang M, Sun W, Shi C

Neuropsychiatric Disease and Treatment 2025, 21:383-393

Published Date: 27 February 2025

Original Research

Correlation Between Monocyte Count, Monocyte–Lymphocyte Ratio, and Other Inflammatory Cells With Sleep and Psychiatric Symptoms in First-Episode Schizophrenia Patients

Hu C, Du N, Li J, Chen L, Meng X, Yao L, Yu T, Shi L, Zhang X

Neuropsychiatric Disease and Treatment 2025, 21:373-381

Published Date: 26 February 2025

Original Research

Fibroblast Growth Factor 21 Protects Against Cerebral Ischemia/Reperfusion Injury by Inhibiting Oxidative Stress and Ferroptosis

Li J, Jiang H, Bai W, Yang Y, Zhou G, Chen W, Shao J

Neuropsychiatric Disease and Treatment 2025, 21:355-371

Published Date: 25 February 2025

Short Report

Prevalence and Correlates of Diurnal Mood Variation in Chinese Adolescents with Major Depressive Disorder and Anxiety Symptoms: A Cross-Sectional Study

Duan J, Zhang Y, Tao J, Fan X

Neuropsychiatric Disease and Treatment 2025, 21:347-353

Published Date: 21 February 2025

Clinical Trial Report

Association of Blood Pressure with Neurological Function Decline and Functional Outcome in Patients of Watershed Infarction

Yang L, Zhang T, Liu X, Chen G, Ding P, Li W, Liao H, Yu D, Liu J, Yue W

Neuropsychiatric Disease and Treatment 2025, 21:335-346

Published Date: 19 February 2025

Study Protocol

Efficacy of Magnetic Seizure Therapy in Patients with Schizophrenia and Combined fMRI-EEG to Explore the Regulatory Mechanisms of Brain Networks

Wei S, Chen B, Guo Z, Zhang H, Li J, Hu X, Yang C, Li J, Li X, Liu Z, Xu Y, Liu S

Neuropsychiatric Disease and Treatment 2025, 21:323-334

Published Date: 19 February 2025

Original Research

Study on the Molecular Mechanism of Baicalin Phosphorylation of Tau Protein Content in a Cell Model of Intervention Cognitive Impairment

Li J, Zhao C, Guan D, Liu C

Neuropsychiatric Disease and Treatment 2025, 21:309-322

Published Date: 19 February 2025

Original Research

Usefulness of Serum NOX4 as a Potential Biomarker to Predict Early Neurological Deterioration and Poor Outcome of Spontaneous Intracerebral Hemorrhage: A Prospective Observational Study

Wu X, He H, Shen D, Ye X, Chen Z, Zou S, Zhou K, Ye X, Zhang Z, Li H, Liu J

Neuropsychiatric Disease and Treatment 2025, 21:295-307

Published Date: 19 February 2025

Original Research

Modulating Gut Microbiota: The Mechanism of Electroacupuncture at the “Siguan” Acupoints in Alleviating Post-Stroke Depression

Li Z, Li L, Xu H, Kang Z, Shi X, Zhang P, Ye H

Neuropsychiatric Disease and Treatment 2025, 21:281-294

Published Date: 14 February 2025

Original Research

Electroencephalogram (EEG) Based Prediction of Attention Deficit Hyperactivity Disorder (ADHD) Using Machine Learning

Kim JW, Kim BN, Kim JI, Yang CM, Kwon J

Neuropsychiatric Disease and Treatment 2025, 21:271-279

Published Date: 13 February 2025

Original Research

The Effects of Hyperlipidemia on Postoperative Cognitive Dysfunction in Patients Undergoing Laparoscopic Gynecological Tumor Surgery

Shen H, Xiong Y, Liang Y, Liu Z, Guo L, Qin Y, He J, Lin F

Neuropsychiatric Disease and Treatment 2025, 21:259-269

Published Date: 13 February 2025

Letter

Propionic Acid-Producing Bacteria as Provocateurs of Anxiety and Depression? [Letter]

Prescott SL, Logan AC

Neuropsychiatric Disease and Treatment 2025, 21:257-258

Published Date: 6 February 2025

Original Research

The Prevalence of Depression Among Parkinson’s Disease Patients in Saudi Arabia: A Cross-Sectional Study

Al-Qahtani Z, Alqahtani ASM, Alzuhairi AMS, Qarah M, Alqarni AA, Alqahtani AOM, AlShehri FAA, Alqathanin MAA, Alshahrani OMO, Alqahtani MAF, Mahmood SE

Neuropsychiatric Disease and Treatment 2025, 21:241-256

Published Date: 4 February 2025

Original Research

Factors Affecting Negative Symptoms in Schizophrenia and Their Relationship with Anxiety and Depression

Zeng G, Liang R, Xiao L, Cao W, Zhou W, Wang W, Liu C, Zhou H, Shi X, Chen B, Chen W

Neuropsychiatric Disease and Treatment 2025, 21:229-240

Published Date: 4 February 2025

Review

Characteristics of Parthenogenetic Stem Cells and Their Potential Treatment Strategy for Central Nervous System Diseases

Cai H, Huang J, Wang W, Lin W, Ahmed W, Lu D, Quan J, Chen L

Neuropsychiatric Disease and Treatment 2025, 21:213-227

Published Date: 3 February 2025

Review

Research Progress on Neural Processing of Hand and Forearm Tactile Sensation: A Review Based on fMRI Research

Chen H, Fu S, Zhi X, Wang Y, Liu F, Li Y, Ren F, Zhang J, Ren L, Wang Y

Neuropsychiatric Disease and Treatment 2025, 21:193-212

Published Date: 31 January 2025

Original Research

Social Anxiety Symptoms in The Visually Impaired Versus Healthy Control: Saudi Arabian Samples

Alsubaie SS

Neuropsychiatric Disease and Treatment 2025, 21:185-191

Published Date: 31 January 2025

Review

Insufficient Evidence to Recommend Shu Mian Capsule in Managing Depression With or Without Comorbid Insomnia: A Systematic Review With Meta-Analysis and Trial Sequential Analysis

Zhao FY, Xu P, Kennedy GA, Jin X, Wang YM, Zhang WJ, Yue LP, Ho YS, Fu QQ, Conduit R

Neuropsychiatric Disease and Treatment 2025, 21:167-183

Published Date: 31 January 2025

Original Research

Differentiations in Illness Duration, Thyroid-Stimulating Hormone, Glucose and P300 Latency Between Drug-Naïve Unipolar and Bipolar Depression: A Comparative Cross-Sectional Study

Li C, Yang L, Zhang Q, Zhang Y, Li R, Jia F, Wang L, Ma X, Yao K, Tian H, Liu Z, Zhuo C

Neuropsychiatric Disease and Treatment 2025, 21:157-166

Published Date: 29 January 2025

Review

Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity

Kinderlehrer DA

Neuropsychiatric Disease and Treatment 2025, 21:141-155

Published Date: 29 January 2025

Clinical Trial Report

Predictive Value of NT-proBNP for Functional Outcome of Ischemic Stroke Without Cardiac Disease: A Prospective, Observational Study

Liu R, Chen G, Zhao N, Yue W

Neuropsychiatric Disease and Treatment 2025, 21:129-140

Published Date: 27 January 2025

Original Research

Functional Remediation Improves Serum BDNF and TrkB Levels in Euthymic Patients with Bipolar Disorder: A Randomized Trial Study

Li R, Li J, Ji SS, Li D, Chu L, Zhang J, Sun X, Luo X, Zhang Y

Neuropsychiatric Disease and Treatment 2025, 21:115-128

Published Date: 25 January 2025

Review

White Matter Injury in Central Nervous System Disorders

Zheng L, Wang X, Li P, Hao Y, Zhang H, Chen H, Zheng Z

Neuropsychiatric Disease and Treatment 2025, 21:107-114

Published Date: 24 January 2025

Review

Clinical Utility of Zuranolone for Postpartum Depression: A Narrative Review

Giannopoulos A, Singh J, Deligiannidis KM

Neuropsychiatric Disease and Treatment 2025, 21:93-105

Published Date: 25 January 2025

Original Research

Multimodal Magnetic Resonance Findings in Parkinson’s Disease With “Antecedent Essential Tremor”: A Case Series of a Large Kindred

Kong Y, Yao L, Xiao X, Chen A, Wang K, Yan H, Sun R, Liu R, Kong Q

Neuropsychiatric Disease and Treatment 2025, 21:79-92

Published Date: 22 January 2025

Review

A Systematic Review of Knowledge, Attitude, and Perception Towards Electroconvulsive Therapy (ECT) in Africa

Abaatyo J, Kaggwa MM

Neuropsychiatric Disease and Treatment 2025, 21:67-77

Published Date: 13 January 2025

Original Research

Emerging Implications of Serum Resolvin D2 as a Biochemical Marker for Severity Assessment and Prognosis Prediction Following Moderate-Severe Traumatic Brain Injury: A Prospective Cohort Study

Zong H, Zong Y, Li J, Zhao S, Wu W, Chen R, Zhao G, Li Z

Neuropsychiatric Disease and Treatment 2025, 21:53-65

Published Date: 10 January 2025

Original Research

Cognitive Disorders In Acquired Sensorineural Hearing Loss, At The Ent Department Of The “Village Bondeko” Center, In Kinshasa

Masamba GR, Sokolo Gedikondele J, Longo-Mbenza B, Nganga Nkanga MS, Matanda Nzanza R, Matonda-ma-Nzuzi T, Ikanga J, Nge Okwe A, Lema Mabwaka G, Mawalala Malengele H, Nangi Mampuya C, Lumbu Malundama D

Neuropsychiatric Disease and Treatment 2025, 21:37-52

Published Date: 7 January 2025

Original Research